Treating Neuropsychiatric Symptoms in Dementia With Lewy Bodies: A Randomized Controlled-trial

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Alzheimer Disease and Associated Disorders

• Publication date

  2010-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/WAD.0b013e3181e6a4d7PMID 20625270
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Missing data

  2019cited by this paper
• Treatment of Delusions in Dementia with Lewy Bodies – Response to Pharmacotherapy

  2007cited by this paper
• Quetiapine for agitation or psychosis in patients with dementia and parkinsonism

  2007influential reference
• Statistical analysis of longitudinal psychiatric data with dropouts.

  2007cited by this paper
• Distinguishing Lewy body dementias from Alzheimer’s disease

  2007cited by this paper
• A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia.

  2007cited by this paper
• Cholinesterase inhibitors in dementia with Lewy bodies—a comparative analysis

  2007cited by this paper
• The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease.

  2006cited by this paper
• Diagnosis and management of dementia with Lewy bodies

  2005cited by this paper
• PAROXETINE AND IMPROVEMENT OF VISUAL HALLUCINATIONS IN PATIENTS WITH DEMENTIA WITH LEWY BODIES

  2005cited by this paper
• Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.

  2004cited by this paper
• Dementia with Lewy Bodies: Implications for Clinical Trials

  2004cited by this paper
• Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.

  2004cited by this paper
• Mirtazapine completely relieves severe insomnia in a patient with Lewy body dementia

  2003cited by this paper
• Probable Dementia with Lewy Bodies and Risperidone-Induced Delirium

  2002cited by this paper
• Efficacy of Olanzapine in the Treatment of Psychosis in Dementia with Lewy Bodies

  2002influential reference
• Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.

  2000influential reference
• Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies.

  2000cited by this paper
• The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement.

  2000cited by this paper
• Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.

  1999cited by this paper
• Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease

  1998cited by this paper
• Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease.

  1998cited by this paper
• The Empirical Behavioral Pathology in Alzheimer's Disease (E-BEHAVE-AD) Rating Scale

  1996cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• Neuroleptic sensitivity to risperidone in Lewy body dementia.

  1995cited by this paper
• Assessment of Cognitive, Psychiatric, and Behavioral Disturbances in Patients with Dementia: The Neurobehavioral Rating Scale

  1992influential reference
• Clinical diagnosis of Alzheimer's disease

  1991cited by this paper
• Effect of Citalopram, a Selective 5‐HT Reuptake Blocker, in Emotionally Disturbed Patients with Dementia a

  1991cited by this paper
• Assessment of the severely impaired patient: Description and validation of a new neuropsychological test battery.

  1990cited by this paper
• The Clinical Efficacy of Citalopram in Treatment of Emotional Disturbances in Dementia Disorders a Nordic Multicentre Study

  1990cited by this paper
• The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients

  1987cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Lived experiences of Lewy body dementia diagnosis and care in Ireland

  2026cites this paper
• Antidepressant use and cognitive decline in patients with dementia: a national cohort study

  2025cites this paper
• Electroconvulsive therapy ameliorates treatment-resistant depression in patient with Lewy body dementia

  2025cites this paper
• Antidepressant use in dementia: Assessing effective strategies for a vulnerable population.

  2025cites this paper
• Risperidone for the Treatment of Dementia-Related Psychosis: A Systematic Review and Meta-Analysis

  2024cites this paper
• Neuroanatomical substrates of depression in dementia with Lewy bodies and Alzheimer’s disease

  2024cites this paper
• Association of Anticholinergic Drug Burden With Cognitive and Functional Decline Over Time in Dementia With Lewy Bodies: 1-Year Follow-Up Study

  2024cites this paper
• Insights into the management of Lewy body dementia: a scoping review

  2024cites this paper
• The high cost of care and limited evidence on cost-effective strategies for Lewy body dementia: systematic review of evidence

  2024cites this paper
• Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance

  2023cites this paper
• Demenz mit Lewy-Körpern: alte und neue Erkenntnisse – Teil 2: Behandlung

  2023cites this paper
• Pimavanserin Treatment for Psychosis in Patients with Dementia with Lewy Bodies: A Case Series

  2023cites this paper
• Depression in dementia with Lewy bodies: a critical update

  2023cites this paper
• Deep venous thrombosis and hyponatremia associated with citalopram use for behavioral symptoms in Parkinson’s disease: a case report

  2023cites this paper
• Burden of Illness Among Patients with Psychosis due to Dementia with Lewy Bodies and Other Dementias

  2023cites this paper
• Overview of late-onset psychoses

  2023cites this paper
• Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations

  2022cites this paper
• The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia

  2022cites this paper
• Gender differences in Parkinson's disease with dementia and dementia with Lewy bodies

  2022cites this paper
• Overview of therapeutic targets in management of dementia.

  2022cites this paper
• Recent advances in Lewy body dementia: A comprehensive review.

  2022cites this paper
• Current Therapies and Drug Development Pipeline in Lewy Body Dementia: An Update

  2022cites this paper
• Systematic review of pharmacological interventions for people with Lewy body dementia

  2022cites this paper
• Case Study 3: A 58-Year-Old Woman Referred for Evaluation of Suspected Alzheimer Dementia.

  2022cites this paper
• Comparative Efficacy, Safety, Tolerability, and Effectiveness of Antipsychotics in The Treatment of Dementia-Related Psychosis (DRP): A Systematic Literature Review

  2021cites this paper
• Treatment Efficacy and Acceptabilityof Pharmacotherapies for Dementia with Lewy Bodies: A Systematic Review and Network Meta-Analysis.

  2021cites this paper
• ALTERAÇÕES NEUROPSICOLÓGICAS NA DEMÊNCIA POR CORPOS DE LEWY

  2021cites this paper
• Das Spektrum der atypischen Parkinson-Syndrome im klinischen Alltag

  2021cites this paper
• Outcome Measures for Dementia With Lewy Body Clinical Trials

  2021cites this paper
• Pharmacological Agents to Treat Severe Neuropsychiatric Symptoms in Major Neurocognitive Disorders

  2020cites this paper
• Treatment Options for Dementia with Lewy Bodies: A Network Meta-Analysis of Randomised Control Trials

  2020cites this paper
• Effect of biological treatments on psychotic symptoms in lewy body disease: A systematic review and meta‐analysis of randomized controlled trials

  2020cites this paper
• Pharmacotherapy of Psychosis in Parkinson’s Disease

  2020cites this paper
• New evidence on the management of Lewy body dementia.

  2020cites this paper
• Treatment of psychosis in Parkinson's disease and dementia with Lewy Bodies: A review.

  2020cites this paper
• Major Neurocognitive Disorder with Behavioral Disturbance (Behavioral and Psychological Symptoms of Dementia—BPSD)

  2019cites this paper
• Dementia with Lewy bodies: Challenges in the diagnosis and management

  2019cites this paper
• Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA

  2019cites this paper
• Treatment of psychiatric disturbances in hypokinetic movement disorders

  2019cites this paper
• Burden of Disease and Current Management of Dementia with Lewy Bodies: A Literature Review

  2019cites this paper
• Clinical drug development for dementia with Lewy bodies: past and present

  2019cites this paper
• Terminology and assessment tools of psychosis: A systematic narrative review

  2019cites this paper
• Dementia.

  2018cites this paper
• Advances in the pharmacotherapeutic management of dementia with Lewy bodies

  2018influential citation
• Lewy Body Dementia.

  2018cites this paper
• Pharmacotherapy in dementia with lewy bodies

  2017cites this paper
• Assessment of the visual thalamic circuitry in hallucinations in dementia with Lewy bodies

  2017cites this paper
• Benefits and harms of atypical antipsychotics for agitation in adults with dementia.

  2017cites this paper
• Non-pharmacological interventions for Lewy body dementia: a systematic review

  2017cites this paper
• Pharmacological management of behavioural and psychological symptoms of dementia

  2016cites this paper
• Poverty and Slowness of Voluntary Movement

  2016cites this paper
• The Treatment of Behavioral and Psychological Symptoms of Dementia: Weighing Benefits and Risks.

  2016cites this paper
• Development of educational resources regarding Lewy body dementia for nurses in long-term care

  2016influential citation
• Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia

  2016cites this paper
• Epidemiology and Clinical Features of Psychosis in Later Lif Disorder Epidemiology

  2015cites this paper
• Comprehensive treatment of dementia with Lewy bodies

  2015cites this paper
• Psychosis in Later Life: A Review and Update

  2015cites this paper
• Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.

  2015cites this paper
• Treating psychosis in movement disorder patients: a review

  2014cites this paper
• Genetic epidemiology of psychotic symptoms and their treatment in dementia

  2014cites this paper
• Efficacy and Tolerability of Benzodiazepines for the Treatment of Behavioral and Psychological Symptoms of Dementia

  2014cites this paper
• A comparison of the E-BEHAVE-AD, NBRS, and NPI in quantifying clinical improvement in the treatment of agitation and psychosis associated with dementia.

  2013cites this paper
• Dementia, bizarre creatures, and a white knight to the rescue

  2013cites this paper
• Neuropsychiatric Symptoms in Patients with Dementias Associated with Cortical Lewy Bodies: Pathophysiology, Clinical Features, and Pharmacological Management

  2013influential citation
• Clinical Trials of Dementia With Lewy Bodies and Parkinson’s Disease Dementia

  2012cites this paper
• Behavioral Disturbance in Dementia

  2012cites this paper
• New wine in old bottle: late-life psychosis.

  2011cites this paper
• Incidence and predictive factors of depressive symptoms in Alzheimer's disease: The REAL.FR study

  2011cites this paper
• Efficacy and Tolerability of Antidepressants in the Treatment of Behavioral and Psychological Symptoms of Dementia, A Literature Review of Evidence

  2011cites this paper
• Dementia With Lewy Bodies

  2011cites this paper